Loading...

Caryn Lerman

Title(s)Director, USC Norris Comprehensive Cancer Center
Address1441 Eastlake Avenue
Health Sciences Campus
Los Angeles CA 90033
Phone+1 323 865 0816
vCardDownload vCard
    Other Positions
    Title(s)H. Leslie Hoffman and Elaine S. Hoffman Chair in Cancer Research

    Title(s)Associate Dean for Cancer Programs


    Collapse Overview 
    Collapse Overview
    Dr. Lerman is the H. Leslie and Elaine S. Hoffman Professor in Cancer Research and Director of the USC Norris Comprehensive Cancer Center. Previously, she served as the John H. Glick Professor for Cancer Research and Vice Dean for Strategic Initiatives in the Perelman School of Medicine at the University of Pennsylvania. Prior to her Vice Dean appointment, she served as Senior Deputy Director of the Abramson Cancer Center for 10 years.

    Dr. Lerman is nationally recognized for her cancer prevention research that bridges the fields of neuroscience, pharmacology, genetics and behavioral science. She produced the first empirical data on the outcomes of genetic testing for cancer susceptibility, and was among the first to publish evidence for the genetic basis of cancer risk behaviors. Her pioneering work identifying genetic influences on tobacco use culminated in the first prospective stratified pharmacogenomic trial in the field of tobacco dependence, which has had a considerable impact on the application of precision medicine for tobacco dependence treatment. Supported by her National Cancer Institute (NCI) Outstanding Investigator Award (R35), Dr. Lerman now also leads a highly novel research program that harnesses advances in cognitive neuroscience to promote cancer risk behavior change. She has published over 380 peer reviewed publications, which have been cited over >20,000 times.

    An elected member of the National Academy of Medicine, Dr. Lerman has served as a member of the NCI Board of Scientific Advisors, the National Human Genome Research Advisory Council, and the National Institutes on Drug Abuse Advisory Council. She is also past president of the Society for Research on Nicotine and Tobacco.

    Collapse Research 
    Collapse Research Activities and Funding
    Neural basis of smoking relapse
    NIH/NIDA R01DA041402Apr 1, 2016 - Jan 31, 2021
    Role: Principal Investigator
    Neuroscience-based Interventions for Cancer Risk Behavior Change
    NIH/NCI R35CA197461Aug 1, 2015 - Jul 31, 2022
    Role: Principal Investigator
    UPENN TCORS: Tobacco Product Messaging in a Complex Communication Environment
    NIH/NCI P50CA179546Sep 18, 2013 - Aug 31, 2018
    Role: Co-Principal Investigator
    Retraining Neurocognitive Mechanisms of Cancer Risk Behavior (PQ4)
    NIH/NCI R01CA170297Sep 1, 2012 - Jun 30, 2016
    Role: Principal Investigator
    Cognitive Training for Nicotine Dependence
    NIH/NIDA R01DA030819Sep 30, 2010 - Jun 30, 2015
    Role: Principal Investigator
    Abramson Cancer Center Support Grant
    NIH/NCI P30CA147859Sep 30, 2009 - Sep 29, 2012
    Role: Principal Investigator
    Functional Characterization of OPRM1 A118G in Nicotine Dependence
    NIH/NIDA R21DA027066Sep 30, 2009 - Aug 31, 2011
    Role: Co-Principal Investigator
    Nicotine Abstinence-Induced Cognitive Alterations by COMT Genotype
    NIH/NIDA R03DA027438Sep 15, 2009 - Aug 31, 2012
    Role: Principal Investigator
    Center for Interdisciplinary Research on Nicotine Addiction (CIRNA)
    NIH/NCI P50CA143187Aug 1, 2009 - Jul 31, 2014
    Role: Principal Investigator
    Neural Substrates of Cognitive Deficits in Nicotine Withdrawal
    NIH/NIDA R01DA026849Aug 1, 2009 - May 31, 2013
    Role: Principal Investigator
    Pharmacogenetics of Nicotine Addiction Treatment
    NIH/NIDA U01DA020830Sep 15, 2005 - Jun 30, 2015
    Role: Principal Investigator
    Pharmacogenetic Investigation of Naltrexone
    NIH/NIDA R01DA017555Sep 30, 2003 - Jun 30, 2009
    Role: Principal Investigator
    Transdisciplinary Tobacco Use Research Centers
    NIH/NCI P50CA084718Sep 30, 1999 - Sep 29, 2009
    Role: Principal Investigator
    CANCER GENETICS NETWORK
    NIH/NCI U24CA078146Aug 1, 1998 - Sep 30, 2007
    Role: Co-Principal Investigator
    Decisions &Outcomes of BRCA1/2 Test for Breast Patients
    NIH/NCI R01CA074861Aug 1, 1997 - May 31, 2003
    Role: Co-Principal Investigator
    Abramson Cancer Center Support Grant
    NIH/NCI P30CA016520Jan 15, 1997 - Sep 29, 2012
    Role: Co-Principal Investigator
    USC Norris Comprehensive Cancer Center (Core) Grant
    NIH/NCI P30CA014089Dec 1, 1996 - Nov 30, 2020
    Role: Co-Principal Investigator
    COMPARING MODELS OF COUNSELING FOR BRCA1/2 TESTING
    NIH/NHGRI R01HG001846Sep 30, 1994 - Jun 30, 2001
    Role: Co-Principal Investigator
    COMPARING MODELS OF PRETEST EDUCATION FOR BRCA1 TESTING
    NIH/NIMH R01MH054435Sep 30, 1994 - Aug 31, 1998
    Role: Principal Investigator
    COUNSELING WOMEN AT RISK FOR BREAST CANCER
    NIH/NCI R01CA063605Sep 30, 1993 - Sep 29, 1997
    Role: Principal Investigator
    BIOBEHAVIORAL LUNG CANCER PREVENTION PROGRAM
    NIH/NCI R01CA063562Sep 10, 1993 - Nov 30, 2003
    Role: Principal Investigator
    PREVENTIVE ONCOLOGY ACADEMIC AWARD
    NIH/NCI K07CA001604Aug 1, 1993 - Jun 30, 1996
    Role: Principal Investigator
    IMPROVING ADHERENCE IN WOMEN AT RISK FOR BREAST CANCER
    NIH/NCI R01CA057767Sep 30, 1992 - Feb 28, 1998
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Risk of persistent opioid use following major surgery in matched samples of patients with and without cancer. Cancer Epidemiol Biomarkers Prev. 2020 Aug 28. Falcone M, Luo C, Chen Y, Birtwell D, Cheatle M, Duan R, Gabriel PE, He L, Ko EM, Lenz HJ, Mirkovic N, Mowery DL, Ochroch EAA, Paulson ECC, Schriver E, Schnoll RA, Bekelman JE, Lerman C. PMID: 32859580.
      View in: PubMed   Mentions:    Fields:    
    2. Patterns of lapses and recoveries during a quit attempt using varenicline and behavioral counseling among smokers with and without HIV. Psychol Addict Behav. 2020 Jul 20. Ashare RL, Wileyto EP, Logue-Chamberlain E, Gross R, Tyndale RF, Lerman C, Hawk LW, Cinciripini P, George TP, Lubitz SF, Schnoll R. PMID: 32686950.
      View in: PubMed   Mentions:    Fields:    
    3. Toward Precision Medicine for Smoking Cessation: Developing a Neuroimaging-Based Classification Algorithm to Identify Smokers at Higher Risk for Relapse. Nicotine Tob Res. 2020 Jul 16; 22(8):1277-1284. Frank DW, Cinciripini PM, Deweese MM, Karam-Hage M, Kypriotakis G, Lerman C, Robinson JD, Tyndale RF, Vidrine DJ, Versace F. PMID: 31724052.
      View in: PubMed   Mentions:    Fields:    
    4. Genome-Wide Meta-Analyses of FTND and TTFC Phenotypes. Nicotine Tob Res. 2020 05 26; 22(6):900-909. Chen J, Loukola A, Gillespie NA, Peterson R, Jia P, Riley B, Maes H, Dick DM, Kendler KS, Damaj MI, Miles MF, Zhao Z, Li MD, Vink JM, Minica CC, Willemsen G, Boomsma DI, Qaiser B, Madden PAF, Korhonen T, Jousilahti P, Hällfors J, Gelernter J, Kranzler HR, Sherva R, Farrer L, Maher B, Vanyukov M, Taylor M, Ware JJ, Munafò MR, Lutz SM, Hokanson JE, Gu F, Landi MT, Caporaso NE, Hancock DB, Gaddis NC, Baker TB, Bierut LJ, Johnson EO, Chenoweth M, Lerman C, Tyndale R, Kaprio J, Chen X. PMID: 31294817.
      View in: PubMed   Mentions:    Fields:    
    5. Brain Marker Links Stress and Nicotine Abstinence. Nicotine Tob Res. 2020 05 26; 22(6):885-891. Allenby C, Falcone M, Ashare RL, Cao W, Bernardo L, Wileyto EP, Pruessner J, Loughead J, Lerman C. PMID: 31120113.
      View in: PubMed   Mentions:    Fields:    
    6. Evaluation of nicotine patch adherence measurement using self-report and saliva cotinine among abstainers in a smoking cessation trial. Drug Alcohol Depend. 2020 May 01; 210:107967. Schnoll R, Paul Wileyto E, Gross R, Hitsman B, Hawk LW, Cinciripini P, George TP, Benowitz NL, Fen Lubitz S, Ashare R, Tyndale RF, Lerman C. PMID: 32224420.
      View in: PubMed   Mentions:    Fields:    
    7. Genome-wide association meta-analysis of nicotine metabolism and cigarette consumption measures in smokers of European descent. Mol Psychiatry. 2020 Mar 10. Buchwald J, Chenoweth MJ, Palviainen T, Zhu G, Benner C, Gordon S, Korhonen T, Ripatti S, Madden PAF, Lehtimäki T, Raitakari OT, Salomaa V, Rose RJ, George TP, Lerman C, Pirinen M, Martin NG, Kaprio J, Loukola A, Tyndale RF. PMID: 32157176.
      View in: PubMed   Mentions:    Fields:    
    8. The Use of the Nicotine Metabolite Ratio as a Biomarker to Personalize Smoking Cessation Treatment: Current Evidence and Future Directions. Cancer Prev Res (Phila). 2020 03; 13(3):261-272. Siegel SD, Lerman C, Flitter A, Schnoll RA. PMID: 32132120.
      View in: PubMed   Mentions:    Fields:    
    9. Independent association of tobacco use with opioid use disorder in patients of European ancestry with chronic non-cancer pain. Drug Alcohol Depend. 2020 Apr 01; 209:107901. Cheatle MD, Falcone M, Dhingra L, Lerman C. PMID: 32126454.
      View in: PubMed   Mentions:    Fields:    
    10. Impact of early nausea on varenicline adherence and smoking cessation. Addiction. 2020 01; 115(1):134-144. Peng AR, Swardfager W, Benowitz NL, Ahluwalia JS, Lerman C, Nollen NL, Tyndale RF. PMID: 31502736.
      View in: PubMed   Mentions:    Fields:    
    11. Differences in the rate of nicotine metabolism among smokers with and without HIV. AIDS. 2019 05 01; 33(6):1083-1088. Ashare RL, Thompson M, Leone F, Metzger D, Gross R, Mounzer K, Tyndale RF, Lerman C, Mahoney MC, Cinciripini P, George TP, Collman RG, Schnoll R. PMID: 30946162.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    12. Evaluation of a weighted genetic risk score for the prediction of biomarkers of CYP2A6 activity. Addict Biol. 2020 01; 25(1):e12741. El-Boraie A, Taghavi T, Chenoweth MJ, Fukunaga K, Mushiroda T, Kubo M, Lerman C, Nollen NL, Benowitz NL, Tyndale RF. PMID: 30815984.
      View in: PubMed   Mentions: 1     Fields:    
    13. Neural cue reactivity during acute abstinence predicts short-term smoking relapse. Addict Biol. 2020 03; 25(2):e12733. Allenby C, Falcone M, Wileyto EP, Cao W, Bernardo L, Ashare RL, Janes A, Loughead J, Lerman C. PMID: 30806013.
      View in: PubMed   Mentions:    Fields:    
    14. Evaluating the temporal relationships between withdrawal symptoms and smoking relapse. Psychol Addict Behav. 2019 Mar; 33(2):105-116. Robinson JD, Li L, Chen M, Lerman C, Tyndale RF, Schnoll RA, Hawk LW, George TP, Benowitz NL, Cinciripini PM. PMID: 30614717.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Lack of effect of transcranial direct current stimulation (tDCS) on short-term smoking cessation: Results of a randomized, sham-controlled clinical trial. Drug Alcohol Depend. 2019 01 01; 194:244-251. Falcone M, Bernardo L, Wileyto EP, Allenby C, Burke AM, Hamilton R, Cristancho M, Ashare RL, Loughead J, Lerman C. PMID: 30497056.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Got chocolate? Bilateral prefrontal cortex stimulation augments chocolate consumption. Appetite. 2018 12 01; 131:28-35. To C, Falcone M, Loughead J, Logue-Chamberlain E, Hamilton R, Kable J, Lerman C, Ashare RL. PMID: 30171915.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Association of Reduced Nicotine Content Cigarettes With Smoking Behaviors and Biomarkers of Exposure Among Slow and Fast Nicotine Metabolizers: A Nonrandomized Clinical Trial. JAMA Netw Open. 2018 08; 1(4):e181346. Mercincavage M, Lochbuehler K, Wileyto EP, Benowitz NL, Tyndale RF, Lerman C, Strasser AA. PMID: 30627706.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    18. Predicting smoking abstinence with biological and self-report measures of adherence to varenicline: Impact on pharmacogenetic trial outcomes. Drug Alcohol Depend. 2018 09 01; 190:72-81. Peng AR, Schnoll R, Hawk LW, Cinciripini P, George TP, Lerman C, Tyndale RF. PMID: 29986268.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. A Comparison of Direct and Indirect Analytical Approaches to Measuring Total Nicotine Equivalents in Urine. Cancer Epidemiol Biomarkers Prev. 2018 08; 27(8):882-891. Taghavi T, Novalen M, Lerman C, George TP, Tyndale RF. PMID: 29853480.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. Transcranial direct current brain stimulation decreases impulsivity in ADHD. Brain Stimul. 2018 Sep - Oct; 11(5):974-981. Allenby C, Falcone M, Bernardo L, Wileyto EP, Rostain A, Ramsay JR, Lerman C, Loughead J. PMID: 29885858.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism. Pharmacogenet Genomics. 2018 Jan; 28(1):7-16. Tanner JA, Zhu AZ, Claw KG, Prasad B, Korchina V, Hu J, Doddapaneni H, Muzny DM, Schuetz EG, Lerman C, Thummel KE, Scherer SE, Tyndale RF. PMID: 29232328.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    22. Improvement of the association between self-reported pill count and varenicline levels following exclusion of participants with misreported pill count: A commentary on Peng et al. (2017). Addict Behav. 2018 04; 79:14-16. Peng AR, Le Foll B, Morales M, Lerman C, Schnoll R, Tyndale RF. PMID: 29232593.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    23. Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences. Addiction. 2018 03; 113(3):509-523. Chenoweth MJ, Ware JJ, Zhu AZX, Cole CB, Cox LS, Nollen N, Ahluwalia JS, Benowitz NL, Schnoll RA, Hawk LW, Cinciripini PM, George TP, Lerman C, Knight J, Tyndale RF. PMID: 28921760.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    24. Measures and predictors of varenicline adherence in the treatment of nicotine dependence. Addict Behav. 2017 12; 75:122-129. Peng AR, Morales M, Wileyto EP, Hawk LW, Cinciripini P, George TP, Benowitz NL, Nollen NL, Lerman C, Tyndale RF, Schnoll R. PMID: 28728040.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    25. No Effect of Commercial Cognitive Training on Brain Activity, Choice Behavior, or Cognitive Performance. J Neurosci. 2017 08 02; 37(31):7390-7402. Kable JW, Caulfield MK, Falcone M, McConnell M, Bernardo L, Parthasarathi T, Cooper N, Ashare R, Audrain-McGovern J, Hornik R, Diefenbach P, Lee FJ, Lerman C. PMID: 28694338.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    26. Can brain games help smokers quit?: Results of a randomized clinical trial. Drug Alcohol Depend. 2016 Nov 01; 168:112-118. Loughead J, Falcone M, Wileyto EP, Albelda B, Audrain-McGovern J, Cao W, Kurtz MM, Gur RC, Lerman C. PMID: 27635998.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    27. Does cannabis use moderate smoking cessation outcomes in treatment-seeking tobacco smokers? Analysis from a large multi-center trial. Am J Addict. 2016 06; 25(4):291-6. Rabin RA, Ashare RL, Schnoll RA, Cinciripini PM, Hawk LW, Lerman C, Tyndale RF, George TP. PMID: 27187893.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    28. Racial differences in the relationship between rate of nicotine metabolism and nicotine intake from cigarette smoking. Pharmacol Biochem Behav. 2016 09; 148:1-7. Ross KC, Gubner NR, Tyndale RF, Hawk LW, Lerman C, George TP, Cinciripini P, Schnoll RA, Benowitz NL. PMID: 27180107.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    29. Nicotine withdrawal alters neural responses to psychosocial stress. Psychopharmacology (Berl). 2016 07; 233(13):2459-67. Ashare RL, Lerman C, Cao W, Falcone M, Bernardo L, Ruparel K, Hopson R, Gur R, Pruessner JC, Loughead J. PMID: 27087432.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    30. Sleep Disturbance During Smoking Cessation: Withdrawal or Side Effect of Treatment? J Smok Cessat. 2017 Jun; 12(2):63-70. Ashare RL, Lerman C, Tyndale RF, Hawk LW, George TP, Cinciripini P, Schnoll RA. PMID: 28553407.
      View in: PubMed   Mentions:
    31. Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio. J Neuroimmune Pharmacol. 2016 09; 11(3):471-83. Allenby CE, Boylan KA, Lerman C, Falcone M. PMID: 26872457.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    32. Translational Research on Nicotine Dependence. Curr Top Behav Neurosci. 2016; 28:121-50. Falcone M, Lee B, Lerman C, Blendy JA. PMID: 26873019.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    33. Brain Responses to Smoking Cues Differ Based on Nicotine Metabolism Rate. Biol Psychiatry. 2016 08 01; 80(3):190-7. Falcone M, Cao W, Bernardo L, Tyndale RF, Loughead J, Lerman C. PMID: 26805583.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    34. RNA sequencing of transcriptomes in human brain regions: protein-coding and non-coding RNAs, isoforms and alleles. BMC Genomics. 2015 Nov 23; 16:990. Webb A, Papp AC, Curtis A, Newman LC, Pietrzak M, Seweryn M, Handelman SK, Rempala GA, Wang D, Graziosa E, Tyndale RF, Lerman C, Kelsoe JR, Mash DC, Sadee W. PMID: 26597164.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    35. Transcranial Direct Current Brain Stimulation Increases Ability to Resist Smoking. Brain Stimul. 2016 Mar-Apr; 9(2):191-6. Falcone M, Bernardo L, Ashare RL, Hamilton R, Faseyitan O, McKee SA, Loughead J, Lerman C. PMID: 26572280.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    36. Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism. J Nucl Med. 2015 Nov; 56(11):1724-9. Dubroff JG, Doot RK, Falcone M, Schnoll RA, Ray R, Tyndale RF, Brody AL, Hou C, Schmitz A, Lerman C. PMID: 26272810.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    37. Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption. PLoS One. 2015; 10(7):e0126113. Bergen AW, Michel M, Nishita D, Krasnow R, Javitz HS, Conneely KN, Lessov-Schlaggar CN, Hops H, Zhu AZ, Baurley JW, McClure JB, Hall SM, Baker TB, Conti DV, Benowitz NL, Lerman C, Tyndale RF, Swan GE. PMID: 26132489.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    38. The Nicotine Metabolite Ratio is Associated With Early Smoking Abstinence Even After Controlling for Factors That Influence the Nicotine Metabolite Ratio. Nicotine Tob Res. 2016 Apr; 18(4):491-5. Chenoweth MJ, Schnoll RA, Novalen M, Hawk LW, George TP, Cinciripini PM, Lerman C, Tyndale RF. PMID: 26069034.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    39. Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking. PLoS One. 2015; 10(5):e0128109. Tyndale RF, Zhu AZ, George TP, Cinciripini P, Hawk LW, Schnoll RA, Swan GE, Benowitz NL, Heitjan DF, Lerman C. PMID: 26010901.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    40. Nicotine metabolite ratio (3-hydroxycotinine/cotinine) in plasma and urine by different analytical methods and laboratories: implications for clinical implementation. Cancer Epidemiol Biomarkers Prev. 2015 Aug; 24(8):1239-46. Tanner JA, Novalen M, Jatlow P, Huestis MA, Murphy SE, Kaprio J, Kankaanpää A, Galanti L, Stefan C, George TP, Benowitz NL, Lerman C, Tyndale RF. PMID: 26014804.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    41. Initial Evaluation of Fenofibrate for Efficacy in Aiding Smoking Abstinence. Nicotine Tob Res. 2016 Jan; 18(1):74-8. Perkins KA, Karelitz JL, Michael VC, Fromuth M, Conklin CA, Chengappa KN, Hope C, Lerman C. PMID: 25895948.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    42. Test-Retest Reliability and Stability of the Nicotine Metabolite Ratio Among Treatment-Seeking Smokers. Nicotine Tob Res. 2015 Dec; 17(12):1505-9. Hamilton DA, Mahoney MC, Novalen M, Chenoweth MJ, Heitjan DF, Lerman C, Tyndale RF, Hawk LW. PMID: 25732567.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    43. Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial. Lancet Respir Med. 2015 Feb; 3(2):131-138. Lerman C, Schnoll RA, Hawk LW, Cinciripini P, George TP, Wileyto EP, Swan GE, Benowitz NL, Heitjan DF, Tyndale RF. PMID: 25588294.
      View in: PubMed   Mentions: 93     Fields:    Translation:Humans
    44. Working memory-related neural activity predicts future smoking relapse. Neuropsychopharmacology. 2015 May; 40(6):1311-20. Loughead J, Wileyto EP, Ruparel K, Falcone M, Hopson R, Gur R, Lerman C. PMID: 25469682.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    45. Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers. Cancer Epidemiol Biomarkers Prev. 2014 Sep; 23(9):1773-82. Chenoweth MJ, Novalen M, Hawk LW, Schnoll RA, George TP, Cinciripini PM, Lerman C, Tyndale RF. PMID: 25012994.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCTClinical Trials
    46. Large-scale brain network coupling predicts acute nicotine abstinence effects on craving and cognitive function. JAMA Psychiatry. 2014 May; 71(5):523-30. Lerman C, Gu H, Loughead J, Ruparel K, Yang Y, Stein EA. PMID: 24622915.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    47. Nicotine dependence as a moderator of genetic influences on smoking cessation treatment outcome. Drug Alcohol Depend. 2014 May 01; 138:109-17. Leventhal AM, Lee W, Bergen AW, Swan GE, Tyndale RF, Lerman C, Conti DV. PMID: 24667010.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    48. Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion. Addiction. 2013 Dec; 108(12):2202-11. David SP, Strong DR, Leventhal AM, Lancaster MA, McGeary JE, Munafò MR, Bergen AW, Swan GE, Benowitz NL, Tyndale RF, Conti DV, Brown RA, Lerman C, Niaura R. PMID: 23941313.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    49. Effects of tolcapone on working memory and brain activity in abstinent smokers: a proof-of-concept study. Drug Alcohol Depend. 2013 Dec 15; 133(3):852-6. Ashare RL, Wileyto EP, Ruparel K, Goelz PM, Hopson RD, Valdez JN, Gur RC, Loughead J, Lerman C. PMID: 24095246.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    50. Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence. Mol Psychiatry. 2014 Jul; 19(7):801-10. Turner JR, Ray R, Lee B, Everett L, Xiang J, Jepson C, Kaestner KH, Lerman C, Blendy JA. PMID: 23999525.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimals
    51. Sensitivity and specificity of a procedure for early human screening of novel smoking cessation medications. Addiction. 2013 Nov; 108(11):1962-8. Perkins KA, Lerman C, Karelitz JL, Jao NC, Chengappa KN, Sparks GM. PMID: 23773319.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    52. Neuroimaging in psychiatric pharmacogenetics research: the promise and pitfalls. Neuropsychopharmacology. 2013 Nov; 38(12):2327-37. Falcone M, Smith RM, Chenoweth MJ, Bhattacharjee AK, Kelsoe JR, Tyndale RF, Lerman C. PMID: 23793356.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    53. No untoward effects of smoking cues in anti-smoking public service announcements. Drug Alcohol Depend. 2013 Nov 01; 133(1):279-82. Falcone M, Lerman C, Cappella JN, Sanborn P, Jepson C, Strasser AA. PMID: 23742844.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    54. Effects of bupropion on cognitive performance during initial tobacco abstinence. Drug Alcohol Depend. 2013 Nov 01; 133(1):283-6. Perkins KA, Karelitz JL, Jao NC, Gur RC, Lerman C. PMID: 23726977.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    55. Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment. Neuropharmacology. 2014 Jan; 76 Pt B:581-91. Ashare RL, Falcone M, Lerman C. PMID: 23639437.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimals
    56. Content matters: neuroimaging investigation of brain and behavioral impact of televised anti-tobacco public service announcements. J Neurosci. 2013 Apr 24; 33(17):7420-7. Wang AL, Ruparel K, Loughead JW, Strasser AA, Blady SJ, Lynch KG, Romer D, Cappella JN, Lerman C, Langleben DD. PMID: 23616548.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    57. Age-related differences in working memory deficits during nicotine withdrawal. Addict Biol. 2014 Sep; 19(5):907-17. Falcone M, Wileyto EP, Ruparel K, Gerraty RT, LaPrate L, Detre JA, Gur R, Loughead J, Lerman C. PMID: 23496760.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    58. Biomarkers for smoking cessation. Clin Pharmacol Ther. 2013 Jun; 93(6):526-38. Bough KJ, Lerman C, Rose JE, McClernon FJ, Kenny PJ, Tyndale RF, David SP, Stein EA, Uhl GR, Conti DV, Green C, Amur S. PMID: 23588313.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    59. Nicotinic acetylcholine receptor variation and response to smoking cessation therapies. Pharmacogenet Genomics. 2013 Feb; 23(2):94-103. Bergen AW, Javitz HS, Krasnow R, Nishita D, Michel M, Conti DV, Liu J, Lee W, Edlund CK, Hall S, Kwok PY, Benowitz NL, Baker TB, Tyndale RF, Lerman C, Swan GE. PMID: 23249876.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    60. The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sex. Cancer Epidemiol Biomarkers Prev. 2013 Apr; 22(4):708-18. Zhu AZ, Renner CC, Hatsukami DK, Swan GE, Lerman C, Benowitz NL, Tyndale RF. PMID: 23371292.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    61. APOE ?4, an Alzheimer's disease susceptibility allele, and smoking cessation. Pharmacogenomics J. 2013 Dec; 13(6):538-43. Ashare RL, Karlawish JH, Wileyto EP, Pinto A, Lerman C. PMID: 23247396.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    62. The DRD4 exon III VNTR, bupropion, and associations with prospective abstinence. Nicotine Tob Res. 2013 Jul; 15(7):1190-200. Bergen AW, Javitz HS, Su L, He Y, Conti DV, Benowitz NL, Tyndale RF, Lerman C, Swan GE. PMID: 23212438.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    63. Effects of smoking cues and argument strength of antismoking advertisements on former smokers' self-efficacy, attitude, and intention to refrain from smoking. Nicotine Tob Res. 2013 Feb; 15(2):527-33. Lee S, Cappella JN, Lerman C, Strasser AA. PMID: 22949578.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    64. DRD1 associations with smoking abstinence across slow and normal nicotine metabolizers. Pharmacogenet Genomics. 2012 Jul; 22(7):551-4. Lee W, Ray R, Bergen AW, Swan GE, Thomas P, Tyndale RF, Benowitz NL, Lerman C, Conti DV. PMID: 22495174.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    65. Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: a pilot feasibility study. Drug Alcohol Depend. 2012 Nov 01; 126(1-2):263-7. Ashare RL, Ray R, Lerman C, Strasser AA. PMID: 22595038.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    66. Comparative dynamics of four smoking withdrawal symptom scales. Addiction. 2012 Aug; 107(8):1501-11. Javitz HS, Lerman C, Swan GE. PMID: 22321019.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    67. µ-Opioid receptor availability in the amygdala is associated with smoking for negative affect relief. Psychopharmacology (Berl). 2012 Aug; 222(4):701-8. Falcone M, Gold AB, Wileyto EP, Ray R, Ruparel K, Newberg A, Dubroff J, Logan J, Zubieta JK, Blendy JA, Lerman C. PMID: 22389047.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    68. Pharmacogenetic association of the galanin receptor (GALR1) SNP rs2717162 with smoking cessation. Neuropsychopharmacology. 2012 Jun; 37(7):1683-8. Gold AB, Wileyto EP, Lori A, Conti D, Cubells JF, Lerman C. PMID: 22373943.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    69. Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes. Hum Genet. 2012 Jan 31. Gold AB, Lerman C. PMID: 22290489.
      View in: PubMed   Mentions: 16     Fields:    
    70. Extended duration therapy with transdermal nicotine may attenuate weight gain following smoking cessation. Addict Behav. 2012 Apr; 37(4):565-8. Schnoll RA, Wileyto EP, Lerman C. PMID: 22244706.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    71. Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials. Neuropsychopharmacology. 2012 Feb; 37(3):641-50. King DP, Paciga S, Pickering E, Benowitz NL, Bierut LJ, Conti DV, Kaprio J, Lerman C, Park PW. PMID: 22048466.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    72. Association of BDNF and COMT genotypes with cognitive processing of anti-smoking PSAs. Genes Brain Behav. 2011 Nov; 10(8):862-7. Falcone M, Jepson C, Sanborn P, Cappella JN, Lerman C, Strasser AA. PMID: 21883922.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    73. The dynamics of the urge-to-smoke following smoking cessation via pharmacotherapy. Addiction. 2011 Oct; 106(10):1835-45. Javitz HS, Swan GE, Lerman C. PMID: 21561501.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    74. Gender-stratified gene and gene-treatment interactions in smoking cessation. Pharmacogenomics J. 2012 Dec; 12(6):521-32. Lee W, Bergen AW, Swan GE, Li D, Liu J, Thomas P, Tyndale RF, Benowitz NL, Lerman C, Conti DV. PMID: 21808284.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    75. A novel recruitment message to increase enrollment into a smoking cessation treatment program: preliminary results from a randomized trial. Health Commun. 2011 Dec; 26(8):735-42. Schnoll RA, Cappella J, Lerman C, Pinto A, Patterson F, Wileyto EP, Bigman C, Leone F. PMID: 21667366.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    76. Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. Proc Natl Acad Sci U S A. 2011 May 31; 108(22):9268-73. Ray R, Ruparel K, Newberg A, Wileyto EP, Loughead JW, Divgi C, Blendy JA, Logan J, Zubieta JK, Lerman C. PMID: 21576462.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansAnimals
    77. Brain activity and emotional processing in smokers treated with varenicline. Addict Biol. 2013 Jul; 18(4):732-8. Loughead J, Ray R, Wileyto EP, Ruparel K, O'Donnell GP, Senecal N, Siegel S, Gur RC, Lerman C. PMID: 21507156.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    78. Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers. Nicotine Tob Res. 2011 Jun; 13(6):498-503. Falcone M, Jepson C, Benowitz N, Bergen AW, Pinto A, Wileyto EP, Baldwin D, Tyndale RF, Lerman C, Ray R. PMID: 21385908.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    79. Smoking cues, argument strength, and perceived effectiveness of antismoking PSAs. Nicotine Tob Res. 2011 Apr; 13(4):282-90. Lee S, Cappella JN, Lerman C, Strasser AA. PMID: 21330273.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    80. Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level. Cancer Epidemiol Biomarkers Prev. 2011 Feb; 20(2):234-8. Strasser AA, Benowitz NL, Pinto AG, Tang KZ, Hecht SS, Carmella SG, Tyndale RF, Lerman CE. PMID: 21212060.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    81. Cross-validation of a new procedure for early screening of smoking cessation medications in humans. Clin Pharmacol Ther. 2010 Jul; 88(1):109-14. Perkins KA, Lerman C, Fonte CA, Mercincavage M, Stitzer ML, Chengappa KN, Jain A. PMID: 20485335.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    82. Mouse model predicts effects of smoking and varenicline on event-related potentials in humans. Nicotine Tob Res. 2010 Jun; 12(6):589-97. Rudnick ND, Strasser AA, Phillips JM, Jepson C, Patterson F, Frey JM, Turetsky BI, Lerman C, Siegel SJ. PMID: 20395358.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    83. Replication and extension of association of choline acetyltransferase with nicotine dependence in European and African American smokers. Hum Genet. 2010 Jun; 127(6):691-8. Wei J, Ma JZ, Payne TJ, Cui W, Ray R, Mitra N, Lerman C, Li MD. PMID: 20383528.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    84. Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapy. Clin Pharmacol Ther. 2010 May; 87(5):553-7. Lerman C, Jepson C, Wileyto EP, Patterson F, Schnoll R, Mroziewicz M, Benowitz N, Tyndale RF. PMID: 20336063.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    85. Varenicline's effects on acute smoking behavior and reward and their association with subsequent abstinence. Psychopharmacology (Berl). 2010 May; 210(1):45-51. Perkins KA, Mercincavage M, Fonte CA, Lerman C. PMID: 20306175.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    86. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers. Biol Psychiatry. 2010 Apr 15; 67(8):715-21. Loughead J, Ray R, Wileyto EP, Ruparel K, Sanborn P, Siegel S, Gur RC, Lerman C. PMID: 20207347.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    87. Nicotine vaccines: will smokers take a shot at quitting? Nicotine Tob Res. 2010 Apr; 12(4):390-7. Leader AE, Lerman C, Cappella JN. PMID: 20185516.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    88. Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence. Neuropsychopharmacology. 2010 May; 35(6):1374-82. Ray R, Mitra N, Baldwin D, Guo M, Patterson F, Heitjan DF, Jepson C, Wileyto EP, Wei J, Payne T, Ma JZ, Li MD, Lerman C. PMID: 20147892.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    89. Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial. Ann Intern Med. 2010 Feb 02; 152(3):144-51. Schnoll RA, Patterson F, Wileyto EP, Heitjan DF, Shields AE, Asch DA, Lerman C. PMID: 20124230.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    90. Nicotinic acetylcholine receptor beta2 subunit (CHRNB2) gene and short-term ability to quit smoking in response to nicotine patch. Cancer Epidemiol Biomarkers Prev. 2009 Oct; 18(10):2608-12. Perkins KA, Lerman C, Mercincavage M, Fonte CA, Briski JL. PMID: 19755656.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    91. Working memory deficits predict short-term smoking resumption following brief abstinence. Drug Alcohol Depend. 2010 Jan 01; 106(1):61-4. Patterson F, Jepson C, Loughead J, Perkins K, Strasser AA, Siegel S, Frey J, Gur R, Lerman C. PMID: 19733449.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    92. Transdisciplinary Tobacco Use Research Centers: research achievements and future implications. Nicotine Tob Res. 2009 Oct; 11(10):1231-44. Baker TB, Cummings KM, Hatsukami DK, Johnson CA, Lerman C, Niaura R, O'Malley SS. PMID: 19633277.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    93. A systems biology network model for genetic association studies of nicotine addiction and treatment. Pharmacogenet Genomics. 2009 Jul; 19(7):538-51. Thomas PD, Mi H, Swan GE, Lerman C, Benowitz N, Tyndale RF, Bergen AW, Conti DV. PMID: 19525886.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    94. Dopamine genes and nicotine dependence in treatment-seeking and community smokers. Neuropsychopharmacology. 2009 Sep; 34(10):2252-64. Bergen AW, Conti DV, Van Den Berg D, Lee W, Liu J, Li D, Guo N, Mi H, Thomas PD, Lessov-Schlaggar CN, Krasnow R, He Y, Nishita D, Jiang R, McClure JB, Tildesley E, Hops H, Tyndale RF, Benowitz NL, Lerman C, Swan GE. PMID: 19494806.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    95. Dosimetry of 11C-carfentanil, a micro-opioid receptor imaging agent. Nucl Med Commun. 2009 Apr; 30(4):314-8. Newberg AB, Ray R, Scheuermann J, Wintering N, Saffer J, Schmitz A, Freifelder R, Karp J, Lerman C, Divgi C. PMID: 19242386.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    96. The effect of smoking cues in antismoking advertisements on smoking urge and psychophysiological reactions. Nicotine Tob Res. 2009 Mar; 11(3):254-61. Kang Y, Cappella JN, Strasser AA, Lerman C. PMID: 19251767.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    97. Severity of tobacco abstinence symptoms varies by time of day. Nicotine Tob Res. 2009 Jan; 11(1):84-91. Perkins KA, Briski J, Fonte C, Scott J, Lerman C. PMID: 19246445.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    98. Evidence for endogenous formation of N'-nitrosonornicotine in some long-term nicotine patch users. Nicotine Tob Res. 2009 Jan; 11(1):99-105. Stepanov I, Carmella SG, Han S, Pinto A, Strasser AA, Lerman C, Hecht SS. PMID: 19246447.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    99. Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes. J Neurogenet. 2009; 23(3):252-61. Ray R, Tyndale RF, Lerman C. PMID: 19169923.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    100. Nicotine dependence: biology, behavior, and treatment. Annu Rev Med. 2009; 60:247-60. Ray R, Schnoll RA, Lerman C. PMID: 19630572.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    101. Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype. Mol Psychiatry. 2009 Aug; 14(8):820-6. Loughead J, Wileyto EP, Valdez JN, Sanborn P, Tang K, Strasser AA, Ruparel K, Ray R, Gur RC, Lerman C. PMID: 19065145.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    102. The STAGE cohort: a prospective study of tobacco use among Swedish twins. Nicotine Tob Res. 2008 Dec; 10(12):1727-35. Furberg H, Lichtenstein P, Pedersen NL, Thornton L, Bulik CM, Lerman C, Sullivan PF. PMID: 18988069.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    103. Cancer epidemiology, biomarkers & prevention, and cancer prevention research: two journals, a common goal. Cancer Epidemiol Biomarkers Prev. 2008 Nov; 17(11):2903-5. Rebbeck TR, Brown PH, Hawk ET, Lerman C, Paskett ED, Sellers TA, Lippman SM. PMID: 18990728.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    104. Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study. Pharmacol Biochem Behav. 2009 Mar; 92(1):6-11. Schnoll RA, Patterson F, Wileyto EP, Tyndale RF, Benowitz N, Lerman C. PMID: 19000709.
      View in: PubMed   Mentions: 101     Fields:    Translation:Humans
    105. Varenicline improves mood and cognition during smoking abstinence. Biol Psychiatry. 2009 Jan 15; 65(2):144-9. Patterson F, Jepson C, Strasser AA, Loughead J, Perkins KA, Gur RC, Frey JM, Siegel S, Lerman C. PMID: 18842256.
      View in: PubMed   Mentions: 105     Fields:    Translation:Humans
    106. Identification of pharmacogenetic markers in smoking cessation therapy. Am J Med Genet B Neuropsychiatr Genet. 2008 Sep 05; 147B(6):712-9. Heitjan DF, Guo M, Ray R, Wileyto EP, Epstein LH, Lerman C. PMID: 18165968.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    107. Variability in initial nicotine sensitivity due to sex, history of other drug use, and parental smoking. Drug Alcohol Depend. 2009 Jan 01; 99(1-3):47-57. Perkins KA, Coddington SB, Karelitz JL, Jetton C, Scott JA, Wilson AS, Lerman C. PMID: 18775605.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    108. Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood. Behav Pharmacol. 2008 Sep; 19(5-6):641-9. Perkins KA, Lerman C, Grottenthaler A, Ciccocioppo MM, Milanak M, Conklin CA, Bergen AW, Benowitz NL. PMID: 18690118.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    109. Gene and gene by sex associations with initial sensitivity to nicotine in nonsmokers. Behav Pharmacol. 2008 Sep; 19(5-6):630-40. Perkins KA, Lerman C, Coddington S, Jetton C, Karelitz JL, Wilson A, Jennings JR, Ferrell R, Bergen AW, Benowitz NL. PMID: 18690117.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    110. Snus use and other correlates of smoking cessation in the Swedish Twin Registry. Psychol Med. 2008 Sep; 38(9):1299-308. Furberg H, Lichtenstein P, Pedersen NL, Bulik CM, Lerman C, Sullivan PF. PMID: 18680625.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    111. Association of retrospective early smoking experiences with prospective sensitivity to nicotine via nasal spray in nonsmokers. Nicotine Tob Res. 2008 Aug; 10(8):1335-45. Perkins KA, Lerman C, Coddington S, Karelitz JL. PMID: 18686181.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    112. Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. Hum Mol Genet. 2008 Sep 15; 17(18):2834-48. Conti DV, Lee W, Li D, Liu J, Van Den Berg D, Thomas PD, Bergen AW, Swan GE, Tyndale RF, Benowitz NL, Lerman C. PMID: 18593715.
      View in: PubMed   Mentions: 79     Fields:    Translation:Humans
    113. Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses. Drug Alcohol Depend. 2008 Nov 01; 98(1-2):77-85. David SP, Johnstone EC, Murphy MF, Aveyard P, Guo B, Lerman C, Munafò MR. PMID: 18562131.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    114. A placebo-controlled trial of modafinil for nicotine dependence. Drug Alcohol Depend. 2008 Nov 01; 98(1-2):86-93. Schnoll RA, Wileyto EP, Pinto A, Leone F, Gariti P, Siegel S, Perkins KA, Dackis C, Heitjan DF, Berrettini W, Lerman C. PMID: 18541389.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    115. Neuroimaging, genetics and the treatment of nicotine addiction. Behav Brain Res. 2008 Nov 21; 193(2):159-69. Ray R, Loughead J, Wang Z, Detre J, Yang E, Gur R, Lerman C. PMID: 18599130.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    116. Primary care physicians' willingness to offer a new genetic test to tailor smoking treatment, according to test characteristics. Nicotine Tob Res. 2008 Jun; 10(6):1037-45. Shields AE, Levy DE, Blumenthal D, Currivan D, McGinn-Shapiro M, Weiss KB, Yucel R, Lerman C. PMID: 18584467.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    117. Assessing dimensions of nicotine dependence: an evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM). Nicotine Tob Res. 2008 Jun; 10(6):1009-20. Piper ME, McCarthy DE, Bolt DM, Smith SS, Lerman C, Benowitz N, Fiore MC, Baker TB. PMID: 18584464.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    118. Molecular genetics of successful smoking cessation: convergent genome-wide association study results. Arch Gen Psychiatry. 2008 Jun; 65(6):683-93. Uhl GR, Liu QR, Drgon T, Johnson C, Walther D, Rose JE, David SP, Niaura R, Lerman C. PMID: 18519826.
      View in: PubMed   Mentions: 125     Fields:    Translation:Humans
    119. Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence. J Psychopharmacol. 2009 Mar; 23(2):168-76. Ray R, Rukstalis M, Jepson C, Strasser A, Patterson F, Lynch K, Lerman C. PMID: 18515446.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    120. Nicotine abstinence-induced cerebral blood flow changes by genotype. Neurosci Lett. 2008 Jun 27; 438(3):275-80. Wang Z, Ray R, Faith M, Tang K, Wileyto EP, Detre JA, Lerman C. PMID: 18499348.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    121. Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion. Clin Pharmacol Ther. 2008 Sep; 84(3):320-5. Patterson F, Schnoll RA, Wileyto EP, Pinto A, Epstein LH, Shields PG, Hawk LW, Tyndale RF, Benowitz N, Lerman C. PMID: 18388868.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    122. Genomics of smoking exposure and cessation: lessons for cancer prevention and treatment. Cancer Prev Res (Phila). 2008 Jul; 1(2):80-3. Penning TM, Lerman C. PMID: 19138939.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsPHPublic Health
    123. Development of procedures for early screening of smoking cessation medications in humans. Clin Pharmacol Ther. 2008 Aug; 84(2):216-21. Perkins KA, Lerman C, Stitzer M, Fonte CA, Briski JL, Scott JA, Chengappa KN. PMID: 18388880.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansPHPublic Health
    124. Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment. Pharmacogenomics J. 2008 Dec; 8(6):391-9. Heitjan DF, Asch DA, Ray R, Rukstalis M, Patterson F, Lerman C. PMID: 18347612.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    125. Increase in anger symptoms after smoking cessation predicts relapse. Drug Alcohol Depend. 2008 May 01; 95(1-2):173-6. Patterson F, Kerrin K, Wileyto EP, Lerman C. PMID: 18328642.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    126. Spiral computed tomography and lung cancer: science, the media, and public opinion. J Clin Oncol. 2007 Dec 20; 25(36):5695-7. Schnoll RA, Wileyto EP, Hornik R, Schiller J, Lerman C. PMID: 18089863.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    127. Neural substrates of abstinence-induced cigarette cravings in chronic smokers. J Neurosci. 2007 Dec 19; 27(51):14035-40. Wang Z, Faith M, Patterson F, Tang K, Kerrin K, Wileyto EP, Detre JA, Lerman C. PMID: 18094242.
      View in: PubMed   Mentions: 112     Fields:    Translation:Humans
    128. Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials. Nicotine Tob Res. 2007 12; 9(12):1251-7. David SP, Strong DR, Munafò MR, Brown RA, Lloyd-Richardson EE, Wileyto PE, Evins AE, Shields PG, Lerman C, Niaura R. PMID: 18058343.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    129. Genetics and smoking cessation improving outcomes in smokers at risk. Am J Prev Med. 2007 Dec; 33(6 Suppl):S398-405. Lerman CE, Schnoll RA, Munafò MR. PMID: 18021915.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    130. Translating basic science to improve pharmacotherapy for nicotine dependence. Nicotine Tob Res. 2007 Nov; 9 Suppl 4:S583-98. Phillips JM, Siegel SJ, Shields AE, Patterson F, Gould TJ, Strasser AA, Ray R, Pinto A, Audrain-McGovern J, Rukstalis M, Perkins KA, Blendy JA, Lerman C. PMID: 18067034.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    131. Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial. Nicotine Tob Res. 2007 Nov; 9(11):1237-41. Ray R, Jepson C, Wileyto EP, Dahl JP, Patterson F, Rukstalis M, Pinto A, Berrettini W, Lerman C. PMID: 17978999.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    132. Genetics and smoking behavior. Curr Psychiatry Rep. 2007 Oct; 9(5):349-57. Schnoll RA, Johnson TA, Lerman C. PMID: 17915073.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    133. Treating tobacco dependence in women. J Womens Health (Larchmt). 2007 Oct; 16(8):1211-8. Schnoll RA, Patterson F, Lerman C. PMID: 17937574.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    134. CHRNA4 and tobacco dependence: from gene regulation to treatment outcome. Arch Gen Psychiatry. 2007 Sep; 64(9):1078-86. Hutchison KE, Allen DL, Filbey FM, Jepson C, Lerman C, Benowitz NL, Stitzel J, Bryan A, McGeary J, Haughey HM. PMID: 17768273.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    135. Translational research in medication development for nicotine dependence. Nat Rev Drug Discov. 2007 Sep; 6(9):746-62. Lerman C, LeSage MG, Perkins KA, O'Malley SS, Siegel SJ, Benowitz NL, Corrigall WA. PMID: 17690709.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansAnimals
    136. Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. Nicotine Tob Res. 2007 Aug; 9(8):821-33. David SP, Brown RA, Papandonatos GD, Kahler CW, Lloyd-Richardson EE, Munafò MR, Shields PG, Lerman C, Strong D, McCaffery J, Niaura R. PMID: 17654295.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    137. CREB1 haplotypes and the relative reinforcing value of nicotine. Mol Psychiatry. 2007 Jul; 12(7):615-7. Ray R, Jepson C, Wileyto P, Patterson F, Strasser AA, Rukstalis M, Perkins K, Blendy J, Lerman C. PMID: 17592483.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    138. Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation. J Subst Abuse Treat. 2008 Mar; 34(2):234-41. Schnoll RA, Epstein L, Audrain J, Niaura R, Hawk L, Shields PG, Lerman C, Wileyto EP. PMID: 17600649.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    139. Associations between Cloninger's temperament dimensions and acute tobacco withdrawal. Addict Behav. 2007 Dec; 32(12):2976-89. Leventhal AM, Waters AJ, Boyd S, Moolchan ET, Heishman SJ, Lerman C, Pickworth WB. PMID: 17624682.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    140. Enhanced identification of smoking-related words during the attentional blink in smokers. Addict Behav. 2007 Dec; 32(12):3077-82. Waters AJ, Heishman SJ, Lerman C, Pickworth W. PMID: 17616446.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    141. CYP2B6 genotype does not alter nicotine metabolism, plasma levels, or abstinence with nicotine replacement therapy. Cancer Epidemiol Biomarkers Prev. 2007 Jun; 16(6):1312-4. Lee AM, Jepson C, Shields PG, Benowitz N, Lerman C, Tyndale RF. PMID: 17548706.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    142. An association of CYP2A6 genotype and smoking topography. Nicotine Tob Res. 2007 Apr; 9(4):511-8. Strasser AA, Malaiyandi V, Hoffmann E, Tyndale RF, Lerman C. PMID: 17454707.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    143. Gender differences in acute tobacco withdrawal: effects on subjective, cognitive, and physiological measures. Exp Clin Psychopharmacol. 2007 Feb; 15(1):21-36. Leventhal AM, Waters AJ, Boyd S, Moolchan ET, Lerman C, Pickworth WB. PMID: 17295582.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCTClinical Trials
    144. CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial. Biol Psychiatry. 2007 Sep 15; 62(6):635-41. Lee AM, Jepson C, Hoffmann E, Epstein L, Hawk LW, Lerman C, Tyndale RF. PMID: 17223085.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCTClinical Trials
    145. Pharmacogenetics and smoking cessation with nicotine replacement therapy. CNS Drugs. 2007; 21(7):525-33. Ray R, Schnoll RA, Lerman C. PMID: 17579497.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    146. Can pharmacogenetics help smokers quit? Pharmacogenomics. 2006 Dec; 7(8):1137-40. Munafò M, Lerman C. PMID: 17184199.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    147. No evidence for a major role of polymorphisms during bupropion treatment. Obesity (Silver Spring). 2006 Nov; 14(11):1863-7. Hu J, Redden DT, Berrettini WH, Shields PG, Restine SL, Pinto A, Lerman C, Allison DB. PMID: 17135598.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    148. Association of OPRM1 A118G variant with the relative reinforcing value of nicotine. Psychopharmacology (Berl). 2006 Oct; 188(3):355-63. Ray R, Jepson C, Patterson F, Strasser A, Rukstalis M, Perkins K, Lynch KG, O'Malley S, Berrettini WH, Lerman C. PMID: 16960700.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    149. Current and emerging pharmacotherapies for treating tobacco dependence. Expert Opin Emerg Drugs. 2006 Sep; 11(3):429-44. Schnoll RA, Lerman C. PMID: 16939383.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimals
    150. New lower nicotine cigarettes can produce compensatory smoking and increased carbon monoxide exposure. Drug Alcohol Depend. 2007 Jan 12; 86(2-3):294-300. Strasser AA, Lerman C, Sanborn PM, Pickworth WB, Feldman EA. PMID: 16930853.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    151. Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence. Biol Psychiatry. 2007 Jan 01; 61(1):111-8. Berrettini WH, Wileyto EP, Epstein L, Restine S, Hawk L, Shields P, Niaura R, Lerman C. PMID: 16876132.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCTClinical Trials
    152. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Clin Pharmacol Ther. 2006 Jun; 79(6):600-8. Lerman C, Tyndale R, Patterson F, Wileyto EP, Shields PG, Pinto A, Benowitz N. PMID: 16765148.
      View in: PubMed   Mentions: 118     Fields:    Translation:Humans
    153. Helping smokers quit through pharmacogenetics. LDI Issue Brief. 2006 May-Jun; 11(6):1-4. Lerman C. PMID: 16827222.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    154. Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence. Pharmacogenomics J. 2006 May-Jun; 6(3):194-9. Dahl JP, Jepson C, Levenson R, Wileyto EP, Patterson F, Berrettini WH, Lerman C. PMID: 16402081.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    155. Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy. Mol Psychiatry. 2006 Apr; 11(4):400-9. Malaiyandi V, Lerman C, Benowitz NL, Jepson C, Patterson F, Tyndale RF. PMID: 16402128.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    156. Evaluating smokers' reactions to advertising for new lower nicotine quest cigarettes. Psychol Addict Behav. 2006 Mar; 20(1):80-4. Shadel WG, Lerman C, Cappella J, Strasser AA, Pinto A, Hornik R. PMID: 16536669.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    157. Lack of association of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiol Biomarkers Prev. 2006 Feb; 15(2):398-400. Munafò MR, Johnstone EC, Wileyto EP, Shields PG, Elliot KM, Lerman C. PMID: 16492936.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    158. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. Neuropsychopharmacology. 2006 Jan; 31(1):231-42. Lerman C, Jepson C, Wileyto EP, Epstein LH, Rukstalis M, Patterson F, Kaufmann V, Restine S, Hawk L, Niaura R, Berrettini W. PMID: 16123753.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    159. A randomized controlled trial of financial incentives for smoking cessation. Cancer Epidemiol Biomarkers Prev. 2006 Jan; 15(1):12-8. Volpp KG, Gurmankin Levy A, Asch DA, Berlin JA, Murphy JJ, Gomez A, Sox H, Zhu J, Lerman C. PMID: 16434580.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    160. Is Swedish snus associated with smoking initiation or smoking cessation? Tob Control. 2005 Dec; 14(6):422-4. Furberg H, Bulik CM, Lerman C, Lichtenstein P, Pedersen NL, Sullivan PF. PMID: 16319367.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    161. Medication screening for smoking cessation: a proposal for new methodologies. Psychopharmacology (Berl). 2006 Mar; 184(3-4):628-36. Perkins KA, Stitzer M, Lerman C. PMID: 16163529.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    162. A randomized pilot study of cognitive-behavioral therapy versus basic health education for smoking cessation among cancer patients. Ann Behav Med. 2005 Aug; 30(1):1-11. Schnoll RA, Rothman RL, Wielt DB, Lerman C, Pedri H, Wang H, Babb J, Miller SM, Movsas B, Sherman E, Ridge JA, Unger M, Langer C, Goldberg M, Scott W, Cheng J. PMID: 16097900.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    163. Pharmacotherapy and pharmacogenetics of nicotine dependence. Am J Psychiatry. 2005 Aug; 162(8):1441-51. Berrettini WH, Lerman CE. PMID: 16055765.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimals
    164. Smoking cessation treatment: pharmacogenetic assessment. Curr Opin Mol Ther. 2005 Jun; 7(3):202-8. Munafò MR, Lerman C, Niaura R, Shields AE, Swan GE. PMID: 15977416.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    165. Increases in hyperactive-impulsive symptoms predict relapse among smokers in nicotine replacement therapy. J Subst Abuse Treat. 2005 Jun; 28(4):297-304. Rukstalis M, Jepson C, Patterson F, Lerman C. PMID: 15925263.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    166. Behavioral consequences of testing for obesity risk. Cancer Epidemiol Biomarkers Prev. 2005 Jun; 14(6):1485-9. Frosch DL, Mello P, Lerman C. PMID: 15941960.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    167. Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women. Pharmacogenet Genomics. 2005 Jun; 15(6):393-8. Colilla S, Lerman C, Shields PG, Jepson C, Rukstalis M, Berlin J, DeMichele A, Bunin G, Strom BL, Rebbeck TR. PMID: 15900212.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    168. Catechol-O-methyl-transferase functional polymorphism and nicotine dependence: an evaluation of nonreplicated results. Cancer Epidemiol Biomarkers Prev. 2005 Jun; 14(6):1384-9. Redden DT, Shields PG, Epstein L, Wileyto EP, Zakharkin SO, Allison DB, Lerman C. PMID: 15941945.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    169. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients. Cancer Epidemiol Biomarkers Prev. 2005 Apr; 14(4):1003-7. Schwartz MD, Lerman C, Brogan B, Peshkin BN, Isaacs C, DeMarco T, Halbert CH, Pennanen M, Finch C. PMID: 15824179.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    170. Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion. Nicotine Tob Res. 2005 Apr; 7(2):257-68. Wileyto EP, Patterson F, Niaura R, Epstein LH, Brown RA, Audrain-McGovern J, Hawk LW, Lerman C. PMID: 16036283.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    171. Barriers to translating emerging genetic research on smoking into clinical practice. Perspectives of primary care physicians. J Gen Intern Med. 2005 Feb; 20(2):131-8. Shields AE, Blumenthal D, Weiss KB, Comstock CB, Currivan D, Lerman C. PMID: 15836545.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    172. Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm. Psychopharmacology (Berl). 2005 Jun; 180(1):41-8. Rukstalis M, Jepson C, Strasser A, Lynch KG, Perkins K, Patterson F, Lerman C. PMID: 15682300.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    173. Treating tobacco dependence: state of the science and new directions. J Clin Oncol. 2005 Jan 10; 23(2):311-23. Lerman C, Patterson F, Berrettini W. PMID: 15637394.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    174. Effects of different nicotine replacement therapies on postcessation psychological responses. Addict Behav. 2005 Jan; 30(1):9-17. Strasser AA, Kaufmann V, Jepson C, Perkins KA, Pickworth WB, Wileyto EP, Rukstalis M, Audrain-McGovern J, Lerman C. PMID: 15561445.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    175. Effect of bupropion on depression symptoms in a smoking cessation clinical trial. Psychol Addict Behav. 2004 Dec; 18(4):362-6. Lerman C, Niaura R, Collins BN, Wileyto P, Audrain-McGovern J, Pinto A, Hawk L, Epstein LH. PMID: 15631608.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    176. Smoking topography predicts abstinence following treatment with nicotine replacement therapy. Cancer Epidemiol Biomarkers Prev. 2004 Nov; 13(11 Pt 1):1800-4. Strasser AA, Pickworth WB, Patterson F, Lerman C. PMID: 15533910.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    177. Translating emerging research on the genetics of smoking into clinical practice: ethical and social considerations. Nicotine Tob Res. 2004 Aug; 6(4):675-88. Shields A, Lerman C, Sullivan P. PMID: 15370164.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    178. Relationship between education and delay discounting in smokers. Addict Behav. 2004 Aug; 29(6):1171-5. Jaroni JL, Wright SM, Lerman C, Epstein LH. PMID: 15236819.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    179. Relation between food reinforcement and dopamine genotypes and its effect on food intake in smokers. Am J Clin Nutr. 2004 Jul; 80(1):82-8. Epstein LH, Wright SM, Paluch RA, Leddy JJ, Hawk LW, Jaroni JL, Saad FG, Crystal-Mansour S, Shields PG, Lerman C. PMID: 15213032.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    180. Interacting effects of genetic predisposition and depression on adolescent smoking progression. Am J Psychiatry. 2004 Jul; 161(7):1224-30. Audrain-McGovern J, Lerman C, Wileyto EP, Rodriguez D, Shields PG. PMID: 15229055.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    181. Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers. Nicotine Tob Res. 2004 Jun; 6(3):501-7. Perkins KA, Lerman C, Keenan J, Fonte C, Coddington S. PMID: 15203784.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    182. Food hedonics and reinforcement as determinants of laboratory food intake in smokers. Physiol Behav. 2004 May; 81(3):511-7. Epstein LH, Wright SM, Paluch RA, Leddy J, Hawk LW, Jaroni JL, Saad FG, Crystal-Mansour S, Lerman C. PMID: 15135024.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCTClinical Trials
    183. Predictors of participation in psychosocial telephone counseling following genetic testing for BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev. 2004 May; 13(5):875-81. Halbert CH, Wenzel L, Lerman C, Peshkin BN, Narod S, Marcus A, Corio C, Demarco T, Bellamy S. PMID: 15159322.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    184. Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: implications for the development of tobacco control programs for cancer patients. Psychooncology. 2004 May; 13(5):346-58. Schnoll RA, Rothman RL, Newman H, Lerman C, Miller SM, Movsas B, Sherman E, Ridge JA, Unger M, Langer C, Goldberg M, Scott W, Cheng J. PMID: 15133775.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    185. Changes in food reward following smoking cessation: a pharmacogenetic investigation. Psychopharmacology (Berl). 2004 Aug; 174(4):571-7. Lerman C, Berrettini W, Pinto A, Patterson F, Crystal-Mansour S, Wileyto EP, Restine SL, Leonard DG, Shields PG, Epstein LH. PMID: 15138759.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    186. Do small lapses predict relapse to smoking behavior under bupropion treatment? Nicotine Tob Res. 2004 Apr; 6(2):357-66. Wileyto P, Patterson F, Niaura R, Epstein L, Brown R, Audrain-McGovern J, Hawk L, Lerman C, Patterson F. PMID: 15203809.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    187. Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial. Ann Intern Med. 2004 Mar 16; 140(6):426-33. Lerman C, Kaufmann V, Rukstalis M, Patterson F, Perkins K, Audrain-McGovern J, Benowitz N. PMID: 15023708.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCTClinical Trials
    188. Comparing cancer patients who enroll in a smoking cessation program at a comprehensive cancer center with those who decline enrollment. Head Neck. 2004 Mar; 26(3):278-86. Schnoll RA, Rothman RL, Lerman C, Miller SM, Newman H, Movsas B, Sherman E, Ridge JA, Unger M, Langer C, Goldberg M, Scott W, Cheng J. PMID: 14999804.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    189. Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling. Nicotine Tob Res. 2004 Feb; 6(1):27-37. Collins BN, Wileyto EP, Patterson F, Rukstalis M, Audrain-McGovern J, Kaufmann V, Pinto A, Hawk L, Niaura R, Epstein LH, Lerman C. PMID: 14982685.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    190. Stress-induced cigarette craving: effects of the DRD2 TaqI RFLP and SLC6A3 VNTR polymorphisms. Pharmacogenomics J. 2004; 4(2):102-9. Erblich J, Lerman C, Self DW, Diaz GA, Bovbjerg DH. PMID: 14732864.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    191. Genetics and drug use as a complex phenotype. Subst Use Misuse. 2004; 39(10-12):1515-69. Lessov CN, Swan GE, Ring HZ, Khroyan TV, Lerman C. PMID: 15587945.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    192. The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial. Pharmacogenomics J. 2004; 4(3):184-92. Lerman C, Wileyto EP, Patterson F, Rukstalis M, Audrain-McGovern J, Restine S, Shields PG, Kaufmann V, Redden D, Benowitz N, Berrettini WH. PMID: 15007373.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCTClinical Trials
    193. Transdisciplinary science applied to the evaluation of treatments for tobacco use. Nicotine Tob Res. 2003 Dec; 5 Suppl 1:S89-99. Baker TB, Hatsukami DK, Lerman C, O'Malley SS, Shields AE, Fiore MC. PMID: 14668089.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    194. Intergenerational transmission of tobacco use and dependence: a transdisciplinary perspective. Nicotine Tob Res. 2003 Dec; 5 Suppl 1:S55-69. Shenassa ED, McCaffery JM, Swan GE, Khroyan TV, Shakib S, Lerman C, Lyons M, Mouttapa M, Niaura RS, Buka SL, Leslie F, Santangelo SL. PMID: 14668087.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    195. Subjective effects of an initial dose of nicotine nasal spray predict treatment outcome. Psychopharmacology (Berl). 2004 Mar; 172(3):271-6. Kaufmann V, Jepson C, Rukstalis M, Perkins K, Audrain-McGovern J, Lerman C. PMID: 14647969.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    196. Predictors of attendance in a randomized clinical trial of nicotine replacement therapy with behavioral counseling. Drug Alcohol Depend. 2003 Nov 24; 72(2):123-31. Patterson F, Jepson C, Kaufmann V, Rukstalis M, Audrain-McGovern J, Kucharski S, Lerman C. PMID: 14636967.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    197. Genes, smoking, and treatment response. Am J Health Syst Pharm. 2003 Sep 15; 60(18):1911. Kaufmann V, Lerman C. PMID: 14521049.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    198. Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial. Health Psychol. 2003 Sep; 22(5):541-8. Lerman C, Shields PG, Wileyto EP, Audrain J, Hawk LH, Pinto A, Kucharski S, Krishnan S, Niaura R, Epstein LH. PMID: 14570538.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCTClinical Trials
    199. Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain. Neuropharmacology. 2003 Jul; 45(1):122-32. Miksys S, Lerman C, Shields PG, Mash DC, Tyndale RF. PMID: 12814665.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    200. Individual differences in nicotine intake per cigarette. Cancer Epidemiol Biomarkers Prev. 2003 May; 12(5):468-71. Patterson F, Benowitz N, Shields P, Kaufmann V, Jepson C, Wileyto P, Kucharski S, Lerman C. PMID: 12750245.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    201. Elucidating the role of genetic factors in smoking behavior and nicotine dependence. Am J Med Genet B Neuropsychiatr Genet. 2003 Apr 01; 118B(1):48-54. Lerman C, Berrettini W. PMID: 12627466.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimals
    202. Pharmacogenetic investigation of smoking cessation treatment. Pharmacogenetics. 2002 Nov; 12(8):627-34. Lerman C, Shields PG, Wileyto EP, Audrain J, Pinto A, Hawk L, Krishnan S, Niaura R, Epstein L. PMID: 12439223.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    203. Applying genetic approaches to the treatment of nicotine dependence. Oncogene. 2002 Oct 21; 21(48):7412-20. Lerman C, Niaura R. PMID: 12379882.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    204. Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing. Cancer Epidemiol Biomarkers Prev. 2002 Oct; 11(10 Pt 1):1115-8. Peshkin BN, Schwartz MD, Isaacs C, Hughes C, Main D, Lerman C. PMID: 12376518.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    205. Non-replication of genetic association studies: is DAT all, folks? Nicotine Tob Res. 2002 Aug; 4(3):247-9. Lerman C, Swan GE. PMID: 12215232.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    206. Mediating mechanisms for the impact of bupropion in smoking cessation treatment. Drug Alcohol Depend. 2002 Jul 01; 67(2):219-23. Lerman C, Roth D, Kaufmann V, Audrain J, Hawk L, Liu A, Niaura R, Epstein L. PMID: 12095672.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCTClinical Trials
    207. Attention-Deficit Hyperactivity Disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program. Nicotine Tob Res. 2001 Nov; 3(4):353-9. Lerman C, Audrain J, Tercyak K, Hawk LW, Bush A, Crystal-Mansour S, Rose C, Niaura R, Epstein LH. PMID: 11694203.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    208. Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations. Cancer Epidemiol Biomarkers Prev. 2001 May; 10(5):475-81. Lawrence WF, Peshkin BN, Liang W, Isaacs C, Lerman C, Mandelblatt JS. PMID: 11352857.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    209. Nicotine metabolism and CYP2D6 phenotype in smokers. Cancer Epidemiol Biomarkers Prev. 2001 Mar; 10(3):261-3. Caporaso NE, Lerman C, Audrain J, Boyd NR, Main D, Issaq HJ, Utermahlan B, Falk RT, Shields P. PMID: 11303596.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    210. Intention to be tested for prostate cancer risk among African-American men. Cancer Epidemiol Biomarkers Prev. 2000 Dec; 9(12):1323-8. Myers RE, Hyslop T, Jennings-Dozier K, Wolf TA, Burgh DY, Diehl JA, Lerman C, Chodak GW. PMID: 11142417.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    211. Spiritual faith and genetic testing decisions among high-risk breast cancer probands. Cancer Epidemiol Biomarkers Prev. 2000 Apr; 9(4):381-5. Schwartz MD, Hughes C, Roth J, Main D, Peshkin BN, Isaacs C, Kavanagh C, Lerman C. PMID: 10794482.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    212. Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence. Mol Psychiatry. 2000 Mar; 5(2):189-92. Lerman C, Caporaso NE, Audrain J, Main D, Boyd NR, Shields PG. PMID: 10822347.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    213. Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. Cancer Epidemiol Biomarkers Prev. 1999 Apr; 8(4 Pt 2):361-7. Lerman C, Hughes C, Benkendorf JL, Biesecker B, Kerner J, Willison J, Eads N, Hadley D, Lynch J. PMID: 10207641.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCTClinical Trials
    214. Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups. Cancer Epidemiol Biomarkers Prev. 1999 Apr; 8(4 Pt 2):329-36. Glanz K, Grove J, Lerman C, Gotay C, Le Marchand L. PMID: 10207637.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    215. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol. 1999 Jan; 18(1):14-20. Lerman C, Caporaso NE, Audrain J, Main D, Bowman ED, Lockshin B, Boyd NR, Shields PG. PMID: 9925041.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    216. Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians. Cancer Epidemiol Biomarkers Prev. 1998 Jun; 7(6):453-8. Shields PG, Lerman C, Audrain J, Bowman ED, Main D, Boyd NR, Caporaso NE. PMID: 9641486.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    217. The role of the serotonin transporter gene in cigarette smoking. Cancer Epidemiol Biomarkers Prev. 1998 Mar; 7(3):253-5. Lerman C, Shields PG, Audrain J, Main D, Cobb B, Boyd NR, Caporaso N. PMID: 9521442.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    218. Depression and self-medication with nicotine: the modifying influence of the dopamine D4 receptor gene. Health Psychol. 1998 Jan; 17(1):56-62. Lerman C, Caporaso N, Main D, Audrain J, Boyd NR, Bowman ED, Shields PG. PMID: 9459071.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    219. Etiology, natural history, management and molecular genetics of hereditary nonpolyposis colorectal cancer (Lynch syndromes): genetic counseling implications. Cancer Epidemiol Biomarkers Prev. 1997 Dec; 6(12):987-91. Lynch HT, Lemon SJ, Karr B, Franklin B, Lynch JF, Watson P, Tinley S, Lerman C, Carter C. PMID: 9419392.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    220. Genetic susceptibility testing in smoking-cessation treatment: one-year outcomes of a randomized trial. Addict Behav. 1997 Nov-Dec; 22(6):741-51. Audrain J, Boyd NR, Roth J, Main D, Caporaso NF, Lerman C. PMID: 9426791.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCTClinical Trials
    221. Gender and ethnic differences in readiness to change smoking behavior. Womens Health. 1997; 3(2):139-50. Audrain J, Gomez-Caminero A, Robertson AR, Boyd R, Orleans CT, Lerman C. PMID: 9332155.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    222. Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change. Health Psychol. 1997 Jan; 16(1):87-99. Lerman C, Gold K, Audrain J, Lin TH, Boyd NR, Orleans CT, Wilfond B, Louben G, Caporaso N. PMID: 9028818.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCTClinical Trials
    223. Investigation of mechanisms linking depressed mood to nicotine dependence. Addict Behav. 1996 Jan-Feb; 21(1):9-19. Lerman C, Audrain J, Orleans CT, Boyd R, Gold K, Main D, Caporaso N. PMID: 8729703.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    224. Awareness of heightened breast cancer risk among first-degree relatives of recently diagnosed breast cancer patients. The High Risk Breast Cancer Consortium. Cancer Epidemiol Biomarkers Prev. 1995 Jul-Aug; 4(5):561-5. Audrain J, Lerman C, Rimer B, Cella D, Steffens R, Gomez-Caminero A. PMID: 7549815.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    225. Utilization of ovarian cancer screening by women at increased risk. Cancer Epidemiol Biomarkers Prev. 1995 Apr-May; 4(3):269-73. Schwartz M, Lerman C, Daly M, Audrain J, Masny A, Griffith K. PMID: 7606202.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    226. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev. 1995 Mar; 4(2):169-73. Struewing JP, Lerman C, Kase RG, Giambarresi TR, Tucker MA. PMID: 7742725.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    227. Recruiting high risk women into a breast cancer health promotion trial. Cancer Epidemiol Biomarkers Prev. 1994 Apr-May; 3(3):271-6. Lerman C, Rimer BK, Daly M, Lustbader E, Sands C, Balshem A, Masny A, Engstrom P. PMID: 8019378.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    228. Biological markers in smoking cessation treatment. Semin Oncol. 1993 Aug; 20(4):359-67. Lerman C, Orleans CT, Engstrom PF. PMID: 8342065.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    229. Feasibility of a telephone survey to recruit health maintenance organization members into a tamoxifen chemoprevention trial. Cancer Epidemiol Biomarkers Prev. 1992 Jul-Aug; 1(5):413-6. Daly M, Seay J, Balshem A, Lerman C, Engstrom P. PMID: 1305474.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    Caryn's Networks
    Concepts (522)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (15)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑